We no longer support this version of your browser.
We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.
Site updates: We have made updates to the logos on our site. This will not impact access to your subscription.
AAP Policy Statement on Cardiovascular Monitoring and Stimulant Drugs for ADHD (Addendum May 2008: On May 28, 2008, the American Academy of Pediatrics (AAP) released a statement on cardiovascular monitoring in children and adolescents taking ADHD medications. The AAP does not recommend screening ECGs unless the patient's history, family history, or the physical examination raises concerns.)